Chiara Cianciaruso

5PUBLICATIONS
45CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity.

Laura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill

|Aug 12, 2021
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models.

Amaia Martinez-Usatorre, Ece Kadioglu, Gael Boivin

|Jul 03, 2021
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.

Marie Siwicki, Nicolas A Gort-Freitas, Marius Messemaker

|Jun 01, 2021
Imaging-based spectrometer-less optofluidic biosensors based on dielectric metasurfaces for detecting extracellular vesicles.

Yasaman Jahani, Eduardo R Arvelo, Filiz Yesilkoy

|Jan 23, 2018
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens.

Mario Leonardo Squadrito, Chiara Cianciaruso, Sarah K Hansen

Pageof 1